Investor Presentaiton
Further analysis shows that price increases drove growth in PMPM spending on brand
name drugs. Across all markets, branded drug prices increased steadily between 2017
and 2020 (see Exhibit 3.2), while utilization remained relatively flat or decreased (see
Exhibit 3.3).
Exhibit 3.2: Price per Unit of Prescription Drugs
700
00
600
500
400
300
200
100
2017 2018 2019 2020 2021
Commercial
2017 2018 2019 2020 2021
Medicaid
2017 2018 2019 2020 2021
Medicare
Source: OHIC analysis of HealthFacts RI data. Medicare fee-for-service data are excluded. Units are defined as 30-day equivalent prescriptions.
Exhibit 3.3: Utilization of Prescription Drugs (Units per 1,000 Members)
6,000
5,000
4,000
3,000
2,000
1,000
0
2017 2018 2019 2020 2021
Commercial
2017 2018 2019 2020 2021
Medicaid
2017 2018 2019 2020 2021
Medicare
Source: OHIC analysis of HealthFacts RI data. Medicare fee-for-service data are excluded. Units are defined as 30-day equivalent prescriptions.
Annual Report: Health Care Spending and Quality in Rhode Island
17View entire presentation